Literature DB >> 21339012

Handwriting in patients with Parkinson disease: effect of L-dopa and stimulation of the sub-thalamic nucleus on motor anticipation.

Christel Bidet-Ildei1, Pierre Pollak, Sonia Kandel, Valérie Fraix, Jean-Pierre Orliaguet.   

Abstract

The present research focused on how patients with Parkinson's disease (PD) produce handwriting sequences. PD patients who were on/off medication or deep brain stimulation treatments had to write lll and lln trigrams. We evaluated their ability to anticipate on-line the last letter in the trigram. The results revealed that in PD patients, contrary to healthy participants, the percentage of time taken by the down-stroke of the second l did not vary as a function of the spatial constraints of the following letter (l or n). In other words, the handwriting of the PD patients did not exhibit any sign of motor anticipation. However, under treatment, PD patients exhibited similar results to healthy participants despite no improvement in movement variability. Taken together these results do not seem consistent with the hypothesis that PD patients do not anticipate future movements because of their movement variability. They are more in agreement with theories that postulate that PD patients have a general deficit in the parallel processing of the components of a motor sequence.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339012     DOI: 10.1016/j.humov.2010.08.008

Source DB:  PubMed          Journal:  Hum Mov Sci        ISSN: 0167-9457            Impact factor:   2.161


  8 in total

1.  Comparison of CNN-Learned vs. Handcrafted Features for Detection of Parkinson's Disease Dysgraphia in a Multilingual Dataset.

Authors:  Zoltan Galaz; Peter Drotar; Jiri Mekyska; Matej Gazda; Jan Mucha; Vojtech Zvoncak; Zdenek Smekal; Marcos Faundez-Zanuy; Reinel Castrillon; Juan Rafael Orozco-Arroyave; Steven Rapcsak; Tamas Kincses; Lubos Brabenec; Irena Rektorova
Journal:  Front Neuroinform       Date:  2022-05-30       Impact factor: 3.739

2.  Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.

Authors:  Meng Wang; Chengliang Lu; Fred Roisen
Journal:  Stem Cells Transl Med       Date:  2012-06-01       Impact factor: 6.940

3.  Examining Motor Anticipation in Handwriting as an Indicator of Motor Dysfunction in Schizophrenia.

Authors:  Yasmina Crespo Cobo; Sonia Kandel; María Felipa Soriano; Sergio Iglesias-Parro
Journal:  Front Psychol       Date:  2022-04-01

4.  Handwriting training in Parkinson's disease: A trade-off between size, speed and fluency.

Authors:  Evelien Nackaerts; Sanne Broeder; Marcelo P Pereira; Stephan P Swinnen; Wim Vandenberghe; Alice Nieuwboer; Elke Heremans
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

5.  Training for Micrographia Alters Neural Connectivity in Parkinson's Disease.

Authors:  Evelien Nackaerts; Jochen Michely; Elke Heremans; Stephan P Swinnen; Bouwien C M Smits-Engelsman; Wim Vandenberghe; Christian Grefkes; Alice Nieuwboer
Journal:  Front Neurosci       Date:  2018-01-19       Impact factor: 4.677

6.  Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.

Authors:  Ann Liebert; Brian Bicknell; E-Liisa Laakso; Gillian Heller; Parastoo Jalilitabaei; Sharon Tilley; John Mitrofanis; Hosen Kiat
Journal:  BMC Neurol       Date:  2021-07-02       Impact factor: 2.474

7.  Biometric handwriting analysis to support Parkinson's Disease assessment and grading.

Authors:  Giacomo Donato Cascarano; Claudio Loconsole; Antonio Brunetti; Antonio Lattarulo; Domenico Buongiorno; Giacomo Losavio; Eugenio Di Sciascio; Vitoantonio Bevilacqua
Journal:  BMC Med Inform Decis Mak       Date:  2019-12-12       Impact factor: 2.796

8.  Levodopa improves handwriting and instrumental tasks in previously treated patients with Parkinson's disease.

Authors:  Thomas Müller; Ali Harati
Journal:  J Neural Transm (Vienna)       Date:  2020-08-19       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.